Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Acute Leukemias - Republican Scientific Medical Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
158 Chapter 11 · Conventional Therapy in Adult <strong>Acute</strong> Lymphoblastic Leukemia: Review of the LALA Program<br />
multicentre trials for treatment of acute lymphoblastic leukemia<br />
in adults. Leukemia 6(Suppl 2):175–177<br />
31. Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP,<br />
Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ (1995) Long-term<br />
follow-up of adults with acute lymphoblastic leukemia in first remission<br />
treated with chemotherapy or bone marrow transplantation.<br />
Ann Intern Med 123:428–431<br />
32. Sebban C, Lepage E, Vernant JP, Gluckman E, Attal M, Reiffers J,<br />
Sutton L, Racadot E, Michallet M, Maraninchi D, et al. for the<br />
French Group of Therapy of Adult <strong>Acute</strong> Lymphoblastic Leukemia<br />
(1994) Allogeneic bone marrow transplantation in adult acute<br />
lymphoblastic leukemia in first complete remission: A comparative<br />
study. J Clin Oncol 12:2580–2587<br />
33. Charrin C, Thomas X, Ffrench M, Le QH, Andrieux J, Mozziconacci<br />
MJ, La JL, Bilhou-Nabera C, Michaux L, Bernheim A, et al. (2004) A<br />
report of the LALA-94 and LALA-SA groups on hypodiploidy with<br />
30 to 39 chromosomes and near-triploidy: 2 possible expressions<br />
of a sole entity conferring poor prognosis in adult acute lymphoblastic<br />
leukemia (ALL). Blood 104:2444–2451<br />
34. Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M,<br />
Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, et al.<br />
(2004) Outcome of allogeneic hematopoietic stem-cell transplantation<br />
in adult patients with acute lymphoblastic leukemia: No difference<br />
in related compared with unrelated transplant in first<br />
complete remission. J Clin Oncol 22:2816–2825<br />
35. Rowe JM, Richards S, Burnett AK, Wiernik PH, Harrison G, Lazarus<br />
HM, Franklin IM, Prentice GH, Durrant JI, Tallman MS, et al. (2001)<br />
Favorable results of allogeneic bone marrow transplantation<br />
(BMT) for adults with Philadelphia (Ph)-chromosome-negative<br />
acute lymphoblastic leukemia (ALL) in first complete remission<br />
(CR): Results from the International ALL trial (MRC UKALL XII/ECOG<br />
E2993). Blood 98:481a<br />
36. Dhedin N, Thomas X, Huguet F, Lhéritier V, Boiron JM, Micléa JM,<br />
Vey N, Kuentz M, Charrin C, Boucheix C, et al. for the LALA Group<br />
(2002) No superiority of autologous stem cell transplantation over<br />
chemotherapy alone in adult Ph-negative ALL in first complete<br />
remission: A long follow-up report combining results of LALA<br />
85, 87 and 94 trials. Blood 100(Suppl 1):217a<br />
37. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O‘Brien S, Estey<br />
EH, Huh YO, Spinolo J, Dicke K, Barlogie B, et al. (1990) Results of<br />
the vincristine, doxorubicin, and dexamethasone regimen in<br />
adults with standard and high-risk acute lymphocytic leukemia.<br />
J Clin Oncol 8:994–1004<br />
38. Boucheix C, David B, Sebban C, Racadot E, Bene MC, Bernard A,<br />
Campos L, Jouault H, Sigaux F, Lepage E, et al. for the French<br />
Group on Therapy for Adult <strong>Acute</strong> Lymphoblastic Leukemia<br />
(1994) Immunophenotype of adult acute lymphoblastic leukemia,<br />
clinical parameters and outcome: An analysis of a prospective trial<br />
including 562 tested patients (LALA-87). Blood 84:1603–1612<br />
39. Sebban C, Browman GP, Lepage E, Fiere D (1995) Prognostic value<br />
of early response to chemotherapy assessed by the day 15 bone<br />
marrow aspiration in adult acute lymphoblastic leukemia: A prospective<br />
analysis of 437 cases and its application for designing induction<br />
chemotherapy trials. Leuk Res 19:861–868<br />
40. Asnafi V, Buzyn A, Thomas X, Huguet F, Vey N, Boiron JM, Reman O,<br />
Cayuela JM, Lhéritier V, Vernant JP, et al. (2005) Impact of TCR status<br />
and genotype on outcome in adult T-cell acute lymphoblastic<br />
leukemia: A LALA-94 study. Blood 105:3072–3078<br />
41. Huguet F, Pigneux A, Delabesse E, Thomas X, Beldjord K, Escoffre-<br />
Barbe M, Harousseau JL, Reman O, Garban F, Buzyn A, et al. for the<br />
Group for Reseach on Adult <strong>Acute</strong> Lymphoblastic Leukemia<br />
(GRAALL) (2005) Blood 106(Suppl 1):(abstr 874)<br />
42. Ellison RR, Mick R, Cuttner J, Schiffer CA, Silver RT, Henderson ES,<br />
Woliver T, Royston I, Davey FR, Glicksman AS, et al. (1991) The effect<br />
of postinduction intensification treatment with cytarabine<br />
and daunorubicin in adult acute lymphoblastic leukemia: A prospective<br />
randomized clinical trial by Cancer and Leukemia Group<br />
B. J Clin Oncol 9:2002–2015<br />
43. Taylor PRA, Reid MM, Bown N, Hamilton PJ, Proctor SJ (1992)<br />
<strong>Acute</strong> lymphoblastic leukemia in patients aged 60 years and over:<br />
A population-based study of incidence and outcome. Blood<br />
80:1813–1817<br />
44. Kantarjian HM, O‘Brien S, Smith T, Estey EH, Beran M, Preti A, Pierce<br />
S, Keating MJ (1994) <strong>Acute</strong> lymphocytic leukaemia in the elderly:<br />
Characteristics and outcome with the vincristine-adriamycin-dexamethasone<br />
(VAD) regimen. Br J Haematol 88:94–100<br />
45. Delannoy A, Ferrant A, Bosly A, Chatelain C, Doyen C, Martiat P,<br />
Michaux JL, Sokal G (1990) <strong>Acute</strong> lymphoblastic leukemia in<br />
the elderly. Eur J Haematol 45:90–93<br />
46. Delannoy A, Sebban C, Cony-Makhoul P, Cazin B, Cordonnier C,<br />
Bouabdallah R, Cahn JY, Dreyfus F, Sadoun A, Vernant JP, et al.<br />
(1997) Age-adapted induction treatment of acute lymphoblastic<br />
leukemia in the elderly and assessment of maintenance with interferon<br />
combined with chemotherapy. A multicentric prospective<br />
study in forty patients. Leukemia 11:1429–1434<br />
47. Einheim S, Ost A, Grimfors G, Grander D, Bjorkholm M (1990) Prolonged<br />
remission induced by interferon in a patient with refractory<br />
T-cell ALL. Lancet i:794–795<br />
48. Ochs J, Brecher ML, Mahoney D, Vega R, Pollock BH, Buchanan GR,<br />
Whitehead VM, Ravindranath Y, Freedman AI (1991) Recombinant<br />
interferon alfa given before and in combination with standard<br />
chemotherapy in children with acute lymphoblastic leukemia in<br />
first marrow relapse: A Pediatric Oncology group pilot study. J Clin<br />
Oncol 9:777–782<br />
49. Meyers JD, Flournoy N, Sanders JE, McGuffin RW, Newton BA, Fisher<br />
LD, Lum LG, Appelbaum FR, Doney K, Sullivan KM, et al. (1987)<br />
Prophylactic use of human leukocyte interferon after allogeneic<br />
marrow transplantation. Ann Intern Med 107:809–816<br />
50. Diaz MO, Rubin CM, Harden A, Ziemin S, Larson RA, Le Beau MM,<br />
Rowley JD (1990) Deletions of interferon genes in acute lymphoblastic<br />
leukemia. New Engl J Med 322:77–82<br />
51. Delannoy A, Cazin B, Thomas X, Bouabdallah R, Boiron JM, Huguet<br />
F, Straetmans N, Zerazhi H, Vernant JP, Dombret H, et al. (2002)<br />
Treatment of acute lymphocytic leukemia in the elderly: An evaluation<br />
of vindesine during induction and of interferon alpha given<br />
as a single agent after comlete remission. Leuk Lymphoma<br />
43:75–81<br />
52. Thomas X, Olteanu N, Charrin C, Lhéritier V, Magaud JP, Fiere D<br />
(2001) <strong>Acute</strong> lymphoblastic leukemia in the elderly: The Edouard<br />
Herriot Hospital experience. Am J Hematol 67:73–83<br />
53. Ottmann OG, Druker BT, Sawyers CL, Goldman JM, Reiffers J, Silver<br />
RT, Tura S, Fischer T, Deininger MW, Schiffer CA, et al. (2002) A<br />
phase 2 study of imatinib in patients with relapsed or refractory<br />
Philadelphia chromosome-positive acute lymphoid leukemias.<br />
Blood 100:1965–1971
Change language